Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_assertion type Assertion NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_head.
- NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_assertion description "[Furthermore, CD16A-158V and G1m3 allotypes enhanced ADCC against opsonized HSV-1-infected fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_provenance.
- NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_assertion evidence source_evidence_literature NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_provenance.
- NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_assertion SIO_000772 26179905 NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_provenance.
- NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_assertion wasDerivedFrom befree-2016 NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_provenance.
- NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_assertion wasGeneratedBy ECO_0000203 NP1290232.RA8dDsyDjRNfA5E0InG7X1U-FPxXkz9lGSSRkFz-lRFMY130_provenance.